Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Sat, 14 Nov 2015 22:18:03 GMT ~ Nexvet Hosting Teleconference to Provide Update on NV-01 Pivotal Study
[at noodls] - DUBLIN, Ireland, Nov. 14, 2015 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologics developer, will host a conference call on Monday, November 16th, 2015 at 9:00 AM Eastern Time to ...
Link: http://www.otcmarkets.com/stock/NVET/company-info Ticker: $NVET OTC Market Place: Not Available CIK code: not found Company name: Nexvet Biopharma plc Incorporated In: $NVET share structure
## source: otcmarkets.com
Market Value: Not Available Shares Outstanding: Not Available Float: Not Available Authorized Shares: Not Available Par Value: Not Available
We are committed to transforming animal medicine by making remarkable biologic therapies available to veterinarians, pets, and their families.
We aim for global leadership in veterinary biologics – leadership in our science, our people, our products, and in education. We believe our proprietary PETization™ technology can empower veterinarians by providing new tools for managing chronic conditions.
We intend to bring a pipeline of biologic therapies into best clinical practice: safe, easier to administer, and more convenient therapies for patients in need.
Our vision sees Nexvet as a key opinion leader in veterinary medicine and relevant biotechnologies, leading discussion and sharing the potential of biologics with everyone who has a passion for animal healthcare.